Last reviewed · How we verify
Perioperative Tachycardia — Treatment Landscape & Competitive Intelligence
2 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Brevibloc In Plastic Container | ESMOLOL | Pfizer | beta-Adrenergic Blocker | Beta-1 adrenergic receptor | 1986-01-01 | |
| Brevibloc | Brevibloc | AOP Orphan Pharmaceuticals AG | Beta-1 adrenergic receptor, Beta-1 adrenergic receptor, Beta-2 adrenergic receptor |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- AOP Orphan Pharmaceuticals AG · 1 drug in Perioperative Tachycardia
- Pfizer · 1 drug in Perioperative Tachycardia
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Perioperative Tachycardia:
- Perioperative Tachycardia treatment updates — RSS
- Perioperative Tachycardia treatment updates — Atom
- Perioperative Tachycardia treatment updates — JSON
Cite this brief
Drug Landscape (2026). Perioperative Tachycardia — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/perioperative-tachycardia. Accessed 2026-06-10.
Related
- Perioperative Tachycardia full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing